These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 20137768

  • 1. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M, Wonnemann M, Schug B, Toal C, Donath F, Pontius A, Pauli K, Brendel E, Blume H.
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [Abstract] [Full Text] [Related]

  • 2. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH.
    Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M, Schug B, Anschütz M, Brendel E, De Nucci G, Blume H.
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [Abstract] [Full Text] [Related]

  • 4. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M, Schug B, Schmücker K, Brendel E, van Zwieten PA, Blume H.
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 6. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast.
    Schug BS, Brendel E, Wonnemann M, Wolf D, Wargenau M, Dingler A, Blume HH.
    Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144
    [Abstract] [Full Text] [Related]

  • 7. Relative bioavailability of a newly developed 5-mg levomethadone hydrochloride IR tablet (L-Polamidon® 5 mg tablets) in comparison with the 5-mg levomethadone hydrochloride oral solution (L-Polamidon® solution for substitution) as reference product.
    Blume HH, Wedemeyer RS, Donath F, Roscher K, Elvert G, Wagner D, Bley O, Vuia A, Todorova-Sanjari M, Villalobos R, Schug B.
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):335-44. PubMed ID: 25669614
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y, Jia J, Liu G, Li S, Lu C, Liu Y, Yu C.
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [Abstract] [Full Text] [Related]

  • 9. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE, Parrillo S, Ercoli MC, Estevez-Parrillo FT.
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [Abstract] [Full Text] [Related]

  • 10. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L.
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [Abstract] [Full Text] [Related]

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 12. Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults.
    Zhang H, Wang S, Wang H, Zhi T, Ren J, Wang Y, Yao Z, Zhang P, Ye N, Zhang R.
    Clin Pharmacol Drug Dev; 2024 May; 13(5):499-505. PubMed ID: 38478175
    [Abstract] [Full Text] [Related]

  • 13. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
    Elshafeey AH, Elsherbiny MA, Fathallah MM.
    Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY, Yoon H, Park GK, Lee YB.
    Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A, Stark JG, Pixton GC, Sommerville KW, Zamora CA, Leibowitz M, Rolleri R.
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Xin L, Chen Q, Chen D, Li Y, Li Y, Wu Q, Zou Y, Wang W, Jia J, Yu C, Liu Y.
    Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1082-1088. PubMed ID: 37132398
    [Abstract] [Full Text] [Related]

  • 20. A novel rizatriptan oral gel formulation: Bioavailability and bioequivalence.
    Tellone V, Dragone P, Picollo R, Rosignoli MT, Garofolo F, Del Vecchio A, Calisti F, Comandini A, Donath F, Schug B, Wedemeyer RS.
    Int J Clin Pharmacol Ther; 2020 Oct; 58(10):583-594. PubMed ID: 32716291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.